Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 78

1.

Basiliximab induction and delayed calcineurin inhibitor initiation in liver transplant recipients with renal insufficiency.

Verna EC, Farrand ED, Elnaggar AS, Pichardo EM, Balducci A, Emond JC, Guarrera JV, Brown RS Jr.

Transplantation. 2011 Jun 15;91(11):1254-60. doi: 10.1097/TP.0b013e318218f0f5.

PMID:
21617588
[PubMed - indexed for MEDLINE]
2.

Preserving renal function in liver transplant recipients with rabbit anti-thymocyte globulin and delayed initiation of calcineurin inhibitors.

Bajjoka I, Hsaiky L, Brown K, Abouljoud M.

Liver Transpl. 2008 Jan;14(1):66-72.

PMID:
18161842
[PubMed - indexed for MEDLINE]
Free Article
3.

A therapeutic exploratory study to determine the efficacy and safety of calcineurin-inhibitor-free de-novo immunosuppression after liver transplantation: CILT.

Goralczyk AD, Schnitzbauer A, Tsui TY, Ramadori G, Lorf T, Obed A.

BMC Surg. 2010 Apr 9;10:15. doi: 10.1186/1471-2482-10-15.

PMID:
20380712
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Basiliximab with delayed introduction of calcineurin inhibitors as a renal-sparing protocol following liver transplantation in children with renal impairment.

Mouzaki M, Yap J, Avinashi V, Babu A, Fu A, Deangelis M, Van Roestel K, Ghanekar A, Kamath B, Avitzur Y, Fecteau A, Jones N, Ling S, Grant D, Ng V.

Pediatr Transplant. 2013 Dec;17(8):751-6. doi: 10.1111/petr.12158. Epub 2013 Sep 30.

PMID:
24118898
[PubMed - indexed for MEDLINE]
5.

Study protocol: a pilot study to determine the safety and efficacy of induction-therapy, de novo MPA and delayed mTOR-inhibition in liver transplant recipients with impaired renal function. PATRON-study.

Schnitzbauer AA, Scherer MN, Rochon J, Sothmann J, Farkas SA, Loss M, Geissler EK, Obed A, Schlitt HJ.

BMC Nephrol. 2010 Sep 14;11:24. doi: 10.1186/1471-2369-11-24.

PMID:
20840760
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Basiliximab improves graft survival in renal transplant recipients with delayed graft function.

Gonçalves LF, Ribeiro AR, Berdichevski R, Joelsons G, Proença MC, Manfro RC.

Transplant Proc. 2007 Mar;39(2):437-8.

PMID:
17362751
[PubMed - indexed for MEDLINE]
7.

Effect of basiliximab on renal allograft rejection within 1 year after transplantation.

Lee BM, Oh CK, Jin SH, Kim JH, Kim SJ, Kim H, Shin GT.

Transplant Proc. 2006 Sep;38(7):2025-8.

PMID:
16979988
[PubMed - indexed for MEDLINE]
8.

Induction therapy with basiliximab allows delayed initiation of cyclosporine and preserves renal function after cardiac transplantation.

Rosenberg PB, Vriesendorp AE, Drazner MH, Dries DL, Kaiser PA, Hynan LS, Dimaio JM, Meyer D, Ring WS, Yancy CW.

J Heart Lung Transplant. 2005 Sep;24(9):1327-31.

PMID:
16143252
[PubMed - indexed for MEDLINE]
9.

Basiliximab induction in adult liver transplant recipients with 93% rejection-free patient and graft survival at 24 months.

Ramirez CB, Doria C, di Francesco F, Iaria M, Kang Y, Marino IR.

Transplant Proc. 2006 Dec;38(10):3633-5. Erratum in: Transplant Proc. 2007 Apr;39(3):779. DiFrancesco, F [corrected to di Francesco, F].

PMID:
17175352
[PubMed - indexed for MEDLINE]
10.

The renal-sparing efficacy of basiliximab in adult living donor liver transplantation.

Lin CC, Chuang FR, Lee CH, Wang CC, Chen YS, Liu YW, Jawan B, Chen CL.

Liver Transpl. 2005 Oct;11(10):1258-64.

PMID:
16184544
[PubMed - indexed for MEDLINE]
Free Article
11.

Anti-CD25 monoclonal antibody coverage allows for calcineurin inhibitor "holiday" in solid organ transplant patients with acute renal dysfunction.

Cantarovich M, Metrakos P, Giannetti N, Cecere R, Barkun J, Tchervenkov J.

Transplantation. 2002 Apr 15;73(7):1169-72.

PMID:
11965054
[PubMed - indexed for MEDLINE]
12.

Induction treatment with low-dose thymoglobulin or basiliximab in renal transplants from older donors.

Gavela Martínez E, Sancho Calabuig A, Escudero Quesada V, Avila Bernabeu AI, Beltrán Catalán S, Morales García AI, Crespo Albiach JF, Pallardó Mateu LM.

Transplant Proc. 2008 Nov;40(9):2900-2. doi: 10.1016/j.transproceed.2008.08.082.

PMID:
19010141
[PubMed - indexed for MEDLINE]
13.

Concomitant basiliximab with low-dose calcineurin inhibitors in children post-liver transplantation.

Arora N, McKiernan PJ, Beath SV, deVille de Goyet J, Kelly DA.

Pediatr Transplant. 2002 Jun;6(3):214-8.

PMID:
12100505
[PubMed - indexed for MEDLINE]
14.

Renal function in renal or liver transplant recipients after conversion from a calcineurin inhibitor to sirolimus.

Bäckman L, Reisaeter AV, Wramner L, Ericzon BG, Salmela K, Brattström C.

Clin Transplant. 2006 May-Jun;20(3):336-9.

PMID:
16824151
[PubMed - indexed for MEDLINE]
15.

[Conversion to rapamycin in liver transpant recipients with renal insufficiency].

Yu S, He XS, Ma Y, Hu AB, Wu LW, Zhu XF.

Nan Fang Yi Ke Da Xue Xue Bao. 2009 Nov;29(11):2276-8. Chinese.

PMID:
19923086
[PubMed - indexed for MEDLINE]
Free Article
16.

Induction with basiliximab plus thymoglobulin is effective and safe in old-for-old renal transplantation: six-month results of a prospective clinical study.

Favi E, Gargiulo A, Spagnoletti G, Salerno MP, Silvestrini N, Valente I, Citterio F.

Transplant Proc. 2010 May;42(4):1114-7. doi: 10.1016/j.transproceed.2010.03.073.

PMID:
20534237
[PubMed - indexed for MEDLINE]
17.

Conversion from a calcineurin inhibitor to everolimus therapy in maintenance liver transplant recipients: a prospective, randomized, multicenter trial.

De Simone P, Metselaar HJ, Fischer L, Dumortier J, Boudjema K, Hardwigsen J, Rostaing L, De Carlis L, Saliba F, Nevens F.

Liver Transpl. 2009 Oct;15(10):1262-9. doi: 10.1002/lt.21827.

PMID:
19790150
[PubMed - indexed for MEDLINE]
Free Article
18.

Influence of basiliximab induction therapy on long term outcome after liver transplantation, a prospectively randomised trial.

Schmeding M, Sauer IM, Kiessling A, Pratschke J, Neuhaus R, Neuhaus P, Neumann UP.

Ann Transplant. 2007;12(3):15-21.

PMID:
18290565
[PubMed - indexed for MEDLINE]
19.

Basiliximab and heart transplantation in Hispanics: the experience in Puerto Rico.

Banchs HL, Carro Jiménez EJ, González V, González Cancel IF, Quintana C, Calderón R, Altieri PI, Rivera C.

Bol Asoc Med P R. 2007 Jul-Sep;99(3):191-6.

PMID:
19610574
[PubMed - indexed for MEDLINE]
20.

Immunosuppression for delayed or slow graft function in primary cadaveric renal transplantation: use of low dose tacrolimus therapy with post-operative administration of anti-CD25 monoclonal antibody.

Gonwa TA, Mai ML, Smith LB, Levy MF, Goldstein RM, Klintmalm GB.

Clin Transplant. 2002 Apr;16(2):144-9.

PMID:
11966785
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk